# Anxiolytic and Analgesic Effects of Melatonin

> **NCT02386319** · PHASE3 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 36 (actual)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02386319
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2021-03
- **Final completion:** 2021-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02386319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02386319, "Anxiolytic and Analgesic Effects of Melatonin". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02386319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*